APA (7th ed.) Citation

Locke, K. W., Maneval, D. C., & LaBarre, M. J. (2019). ENHANZE® drug delivery technology: A novel approach to subcutaneous administration using recombinant human hyaluronidase PH20. Drug Delivery, 26(1), 98. https://doi.org/10.1080/10717544.2018.1551442

Chicago Style (17th ed.) Citation

Locke, Kenneth W., Daniel C. Maneval, and Michael J. LaBarre. "ENHANZE® Drug Delivery Technology: A Novel Approach to Subcutaneous Administration Using Recombinant Human Hyaluronidase PH20." Drug Delivery 26, no. 1 (2019): 98. https://doi.org/10.1080/10717544.2018.1551442.

MLA (9th ed.) Citation

Locke, Kenneth W., et al. "ENHANZE® Drug Delivery Technology: A Novel Approach to Subcutaneous Administration Using Recombinant Human Hyaluronidase PH20." Drug Delivery, vol. 26, no. 1, 2019, p. 98, https://doi.org/10.1080/10717544.2018.1551442.